🔗 Share this article

Chancellor Reeves has stated she is planning "focused measures to tackle cost of living challenges" in the upcoming Budget.

In comments to media outlets, she noted that curbing inflation is a collective duty of both the government and the central bank.

The UK's price growth is expected to be the most elevated among the G7 advanced economies this calendar year and the following year.

Possible Energy Bill Interventions

It is understood the administration could take action to bring down energy bills, such as by slashing the present 5% rate of VAT applied on energy.

An additional approach is to reduce some of the regulatory levies presently included in bills.

Fiscal Limitations and Analyst Predictions

The administration will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much scope there is for these measures.

The view from the majority of economists is that the Chancellor will have to introduce higher taxes or spending cuts in order to adhere to her voluntary borrowing rules.

Earlier on Thursday, estimates indicated there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the lower end of expectations.

"It is a joint responsibility between the central bank and the administration to bear down further on some of the sources of price increases," the Chancellor informed reporters in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Commitments and Global Concerns

While a great deal of the attention has been on expected tax increases, the chancellor said the most recent information from the OBR had not changed her commitment to manifesto promises not to increase rates on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with increasing geopolitical and commercial issues for the fiscal tax moves, probably to be targeted on those "wealthiest."

Global Trade Tensions

Addressing apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests always take priority."

Last week's statement by Chinese authorities to tighten trade restrictions on rare earths and other materials that are essential for advanced tech manufacturing led US President the US President to propose an further 100% import tax on goods from the Asian country, raising the prospect of an all-out trade war between the two largest economies.

The American finance chief called China's decision "economic coercion" and "a international production power grab."

Inquired about accepting the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and called on the Chinese government "not to put up barriers and limit trade."

She said the action was "bad for the world economy and causes further challenges."

"I believe there are fields where we need to confront Chinese policies, but there are also significant prospects to export to China's economy, including banking sector and other areas of the economy. We've got to get that equilibrium appropriate."

The chancellor also confirmed she was collaborating with other major economies "on our own critical minerals approach, so that we are less reliant."

NHS Medicine Pricing and Funding

The Chancellor also admitted that the price the NHS spends on pharmaceuticals could increase as a result of ongoing discussions with the US government and its drugs companies, in exchange for lower tariffs and capital.

A number of the biggest global drug companies have said in recent statements that they are either delaying or canceling projects in the United Kingdom, with some attributing the low prices they are obtaining.

Last month, the Science Minister said the cost the health service pays for drugs would have to increase to stop companies and pharmaceutical investment departing from the UK.

The Chancellor informed media: "We have seen because of the payment system, that clinical trials, new drugs have not been provided in the UK in the extent that they are in other continental states."

"The objective is to make sure that people receiving treatment from the NHS are able to receive the top life-saving treatments in the world. And so we are reviewing these issues, and... seeking to attract additional investment into Britain."